Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Advanz Pharma
Pharma
EU authorities revoke marketing nod for Advanz Pharma's Ocaliva
In light of the suspension being lifted, Ocaliva’s European marketing nod has been revoked “with immediate effect,” Advanz said.
Fraiser Kansteiner
Dec 2, 2024 2:54pm
Intercept's Ocaliva nod in danger after negative FDA adcomm vote
Sep 16, 2024 10:40am
Ocaliva's fate looks bleak after FDA releases new briefing docs
Sep 11, 2024 4:58pm
In appeal, Advanz calls UK fine 'manifestly wrong'
Sep 27, 2022 3:48pm
Advanz bags EU rights to Polypid's prolonged-release antibiotic
Aug 9, 2022 9:54am
Intercept sells international rights to Ocaliva to Advanz
May 5, 2022 11:05am
